PMS expiration of Twynsta on August next year
‘Twynsta(telmisasrtan-amlodipine),’ the top sales hypertension treatment, has active competition ahead for the same substance drug due to expiration of post-marketing surveillance(PMS) on August next year.
A number of domestic pharmaceutical companies are getting ready for the competition by thi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
